About: COVID vaccine

Health 22-04-2022

Industry disputes claims that waiving IP rights will ensure availability of medicines

The European Commission is leading talks on a waiver of intellectual property (IP) rights on COVID vaccines and treatments. However, critics from the pharmaceutical industry argue that changes to the current IP system could jeopardise research and development in their sector.
Coronavirus 07-04-2022

EU health agencies: fourth COVID dose only for over 80s and immunocompromised

European health agencies said that the fourth dose of mRNA COVID-19 vaccination, also known as a second booster shot, is currently only being considered for people who are immunocompromised or over 80 years of age. 
Coronavirus 30-03-2022

EU ministers eyes coordinated approach for second COVID booster

A group of EU countries has urged the European Commission to promote a coordinated approach in administering the fourth COVID-19 vaccine dose as some differences among member states are already looming large.
EU-Africa 22-03-2022

South Africa urged to reject EU offer on COVID waiver

Leading economists have urged South African President Cyril Ramaphosa to reject an EU and US compromise that would provide a temporary waiver on the intellectual property rights on COVID vaccines, warning that “a bad deal is worse than no deal".
Coronavirus 17-02-2022

Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed

An Omicron-specific booster could be ready by August, the CEO of U.S. biotech firm Moderna told Reuters, but the firm is still gathering clinical data to determine whether that vaccine would offer better protection than a new dose of the existing jab.
Coronavirus 11-01-2022

Half of Europe on track to catch Omicron, world economy at risk

More than half of people in Europe will likely catch Omicron by March, the World Health Organization said Tuesday (11 January), as the World Bank warned the contagious variant could hamper global economic recovery.
Economy & Jobs 11-01-2022

Pharma industry calls for stronger IP protection in free trade agreements

Amid global criticism for holding on to vaccine patents during the pandemic, a new study commissioned by the European pharmaceuticals industry claims that integrating stronger intellectual property protection into free trade agreements would benefit the EU economy.
Health 21-12-2021

Rich countries fail to agree aid price for COVID-19 vaccine donations

Wealthy states were stuck at an impasse after failing at a meeting on Tuesday (December 21) to agree on new rules that would allow them to report the donation of surplus COVID-19 vaccines as aid.
Global Europe 30-11-2021

Postponement of WTO ministerial a ‘significant blow’ to COVID vaccine, fishing deals

The postponement of the World Trade Organization's ministerial conference this week all but guarantees months of deadlock on fishing subsidies and a bid to spread COVID-19 vaccines more widely.
Coronavirus 19-11-2021

Plan by wealthy nations to treat COVID vaccines as aid prompts backlash

The question of how COVID vaccines donated by wealthy countries are classified and priced could artificially raise the European Union’s development aid figures by billions of euros, EURACTIV understands.
Special ReportOpinionPromoted content
Health 27-10-2021

It’s Time EU Leaders Ensure COVID-19 Vaccine Equity

The novel coronavirus has shown glaring deficiencies in the world's collective ability to respond to infectious disease outbreaks, with none more evident than wealthy countries' self-destructive unwillingness to cooperate on vaccine equity for the benefit of the entire global population.
Health 26-10-2021

Health Brief: East lags behind in vaccination race

Europe is now battling new spikes of COVID-19 cases, especially in Eastern member states where there is a lower vaccination uptake. This not only stretches the health systems, but puts the conversation on measures needed to stop the virus spread...
Special ReportOpinionPromoted content
Health 13-10-2021

The vaccination race: a public health view

Marathon runners say that the real difficulties, what they call "the wall", appear between km 30 and 35. At this point, physical and mental exhaustion forces some runners to withdraw. We have reached this point with COVID-19. We must find the tools and the strength to keep on running. Finishing this race is critical for all of us. It is critical to the entire world.
Health 28-09-2021

Health Brief: Booster shots. Not if, but when

Welcome to EURACTIV’s Health Brief, your weekly update on all things healthcare in Europe.
Health 21-09-2021

Health Brief: DG SANTE’s to-do list

Welcome to EURACTIV’s very first Health Brief! In this first edition, we spoke to the European Commission's director-general for health and food safety, Sandra Gallina, to find out what is in store this autumn when it comes to health.
Coronavirus 16-08-2021

EU agency examines Roche arthritis drug as possible COVID-19 treatment

Europe's drugs regulator said on Monday (16 August) that it was evaluating the use of Roche's arthritis drug, Actemra, in hospitalised adults with severe COVID-19, in its latest review of a potential coronavirus treatment.
Coronavirus 11-08-2021

Spain gets green light to test homegrown COVID vaccine on humans, PM says

Spain's medicines agency has authorized the first round of clinical trials for the COVID-19 vaccine developed by Spanish company Hipra, Prime Minister Pedro Sanchez said on Wednesday.
Coronavirus 23-07-2021

Delta COVID variant now dominates European region, warn WHO and ECDC

The COVID Delta variant has swept rapidly across Europe to become the dominant strain across much of the region according to new data from European health authorities, who warn that action must be taken to curtail its spread.
Health 15-07-2021

From vaccine race to marathon: What’s next for coping with COVID?

Download PDF  

The COVID-19 virus is not going anywhere any time soon and, as new variants keep cropping up across the globe, vaccine development cannot afford to stand still. There are currently just over 100 vaccines in clinical development worldwide but only...
Coronavirus 15-07-2021

Spanish firm finetunes ‘second generation’ COVID-19 vaccine for EU’s booster campaign

A Spanish company active in animal health stands ready to start clinical trials and get the EU's regulatory go-ahead for a 'deadline-proof' recombinant protein vaccine. EURACTIV spoke with the company's chief of the vaccine programme.
Health 05-07-2021

We need global standards, not double standards, for COVID-19 vaccines 

The EU's decision to only allow people to travel to the region if they are fully vaccinated with a European Medicines Agency (EMA) recognized COVID-19 vaccine is discriminatory and puts vaccine uptake at risk, writes Thabani Maphosa.
Coronavirus 21-05-2021

If we forcibly remove patents on vaccines, we are killing a golden industry

Instead of being sidetracked by the debate on waiving patents on COVID vaccines, the EU must come up with a new pharma strategy and strengthen its pharmaceutical industry, writes Pernille Weiss.
Coronavirus 10-05-2021

EU has not ordered AstraZeneca vaccines beyond June, Breton says

The European Union has not made any new orders for AstraZeneca vaccines beyond June when their contract ends, European Internal Market Commissioner Thierry Breton said on Sunday (9 May), after the EU signed a deal with Pfizer-BioNTech.
Coronavirus 10-05-2021

EU invites ‘concrete’ US plan on lifting vaccine patents

Europe on Saturday (8 May) passed the ball back to Washington in a debate over COVID vaccine patents, pushing the US for a concrete proposal and a commitment to export much-needed jabs.